International Journal of Antimicrobial Agents
Volume 25, Issue 5 , Pages 414-418 , May 2005

Meningitis due to methicillin-resistant Staphylococcus aureus (MRSA): Review of 10 cases

  • Bilgin Arda

      Affiliations

    • Ege University, Medical Faculty, Department of Infectious Diseases and Clinical Microbiology, 35100 Bornova, Izmir, Turkey
    • Corresponding Author InformationCorresponding author.
    • ,
  • Tansu Yamazhan

      Affiliations

    • Ege University, Medical Faculty, Department of Infectious Diseases and Clinical Microbiology, 35100 Bornova, Izmir, Turkey
    • ,
  • Oguz Resat Sipahi

      Affiliations

    • Ege University, Medical Faculty, Department of Infectious Diseases and Clinical Microbiology, 35100 Bornova, Izmir, Turkey
    • ,
  • Sertac Islekel

      Affiliations

    • Ege University, Medical Faculty, Department of Neurosurgery, 35100 Bornova, Izmir, Turkey
    • ,
  • Çagri Buke

      Affiliations

    • Ege University, Medical Faculty, Department of Infectious Diseases and Clinical Microbiology, 35100 Bornova, Izmir, Turkey
    • ,
  • Sercan Ulusoy

      Affiliations

    • Ege University, Medical Faculty, Department of Infectious Diseases and Clinical Microbiology, 35100 Bornova, Izmir, Turkey

Received 5 August 2004 ,Accepted 17 December 2004.

References 

  1. Pintado V, Meseguer MA, Fortum J, et al. Clinical Study of Staphylococcus aureus meningitis. Eur J Clin Microbiol Infect Dis. 2002;21:864–868
  2. Chang WN, Lu CH, Wu JJ, et al. Staphylococcus aureus meningitis in adults: a clinical comparison of infections caused by methicillin-resistant and methicillin-sensitive strains. Infection. 2001;29:245–250
  3. Lu CH, Chang WN. Adults with meningitis caused by oxacillin-resistant Staphylococcus aureus. Clin Infect Dis. 2000;31:723–727
  4. Kralinsky K, Lako J, Dluholucky S, et al. Nosocomial staphylococcal meningitis in neonates successfully treated with intraventricular teicoplanin. Chemotherapy. 1999;45:313–314
  5. Cruciani M, Navara A, Peri GD, et al. Evaluation of intraventricular teicoplanin for the treatment of neurosurgical shunt infections. Clin Infect Dis. 1992;15:285–289
  6. Venditti M, Micozzi A, Serra P, et al. Intraventricular administration of teicoplanin in shunt associated ventriculitis caused by methicillin resistant Staphylococcus aureus. J Antimicrob Chemother. 1988;21:513–515
  7. Performance standards for antimicrobial disc susceptibility tests. Approved standard, M2-A6. Villanova, PA: National Committee for Clinical Laboratory Standards (NCCLS); 1997.
  8. Hardy KJ, Hawkey PM, Gao F, et al. Methicillin-resistant Staphylococcus aureus in the critically ill. Br J Anaesth. 2004;92:121–130
  9. Moellering RC. Pharmacokinetics of vancomycin. J Antimicrob Chemother. 1984;14(Suppl. d):43–52
  10. Young EJ, Ratner R, Clarridge JE. Staphylococcal ventriculitis treated with vancomycin. South Med J. 1981;74:1014–1015
  11. Matsubara H, Makimoto A, Higa T, et al. Successful treatment of meningoencephalitis caused by methicillin-resistant Staphylococcus aureus with intrathecal vancomycin in an allogeneic peripheral blood stem cell transplant recipient. Bone Marrow Transplant. 2003;31:65–67
  12. Quintilliani R, Cooper BW. Current concepts in the treatment of staphylococcal meningitis. J Antimicrob Chemother. 1988;21(Suppl. C):107–112
  13. Stahl JP, Croize J, Wolff M, et al. Poor penetration of teicoplanin into cerebral fluid in patients with bacterial meningitis. J Antimicrob Chemother. 1987;20:141–142
  14. Lee DD, Maserati R, Scheld WM. Evaluation of teicoplanin in experimental Staphylococcus aureus meningitis. In: Proceedings of the abstracts of the 25th conference on the 25th interscience conference on antimicrobial agents and chemotherapy. American Society for Microbiology: Washington, DC, USA; 1985. p. 689 [abstract].
  15. Wai AO, Lo AM, Abdo A, et al. Vancomycin-induced acute interstitial nephritis. Ann Pharmacother. 1998;32:1160–1164
  16. Arda B, Yamazhan T, Sipahi OR, et al. 2003 Mali Yılı talimatının Ege Üniversitesi Tıp Fakültesi Hastanesi’ndeki Bazı Antibiyotiklerin Kullanımı Üzerine Etkisi. Hastane Infeksiyonları Kongresi, Ankara Turkey. Hastane Infeksiyonları Dernegi. Turk J Hosp Infect. 2004;8(Suppl. 2):14
  17. Guldal D, Semin S. The influences of drug companies’ advertising programs on physicians. Int J Health Serv. 2000;30:585–595
  18. Francis BM, Gilbert GL. Survey of neonatal meningitis in Australia: 1987–1989. Med J Aust. 1992;156:240–243
  19. Geyik MF, Kokoglu OF, Hosoglu S, et al. Acute bacterial meningitis as a complication of otitis media and related mortality factors. Yonsei Med J. 2002;43:573–578
  20. Sakamoto T, Kikuchi K, Mineura K, et al. MRSA meningitis in postoperative patients. Report of 4 cases. Jpn J Antibiot. 1990;43:1137–1142
  21. Jensen AG, Espersen F, Skinhoj P, et al. Staphylococcus aureus meningitis: a review of 104 nationwide consecutive cases. Arch Int Med. 1993;153:1902–1908
  22. Morris A, Low ED. Nosocomial bacterial meningitis, including central nervous system shunt infections. Infect Dis Clin North Am. 1999;13:735–750

PII: S0924-8579(05)00049-X

doi: 10.1016/j.ijantimicag.2004.12.005

International Journal of Antimicrobial Agents
Volume 25, Issue 5 , Pages 414-418 , May 2005

Article Tools